Company Filing History:
2 out of 338 
1 out of 4 Years Active: 1977-1984
Title: Claude Paoletti: Innovator in Pharmaceutical Chemistry
Introduction
Claude Paoletti is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. With a total of three patents to his name, Paoletti's work has the potential to impact the medical community significantly.
Latest Patents
Paoletti's latest patents include the synthesis of pyrido[4,3-b]carbazole derivatives, which are derivatives of 9-hydroxy ellipticine. These compounds are prepared for use in the treatment of leukemias and solid tumors. Another patent focuses on 2-N quaternary ammonium salt derivatives of 9-hydroxy ellipticine, also aimed at treating leukemias and solid tumors. His innovative approaches in these areas highlight his commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Claude Paoletti has worked with various organizations, including the Agence Nationale de Valorisation de la Recherche (ANVAR) and the Etablissement Public Dit: Agence Nationale de Valorisation de la Recherche. His experience in these institutions has allowed him to develop and refine his research in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Jean-Bernard Le Pecq and Nguyen Dat-Xuong. Their collaborative efforts have contributed to the advancement of research in the field of cancer treatment.
Conclusion
Claude Paoletti's work in pharmaceutical chemistry, particularly in developing innovative treatments for cancer, showcases his dedication to improving healthcare outcomes. His patents and collaborations reflect a commitment to scientific advancement that is commendable.